Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AK Medical HoldingsHKSE:01789 +1.31%97 EBITDA Margin % is 26.68% as of Dec. 2025, which is 20% below its 10-year median of 33.28. GuruFocus rates HKSE:01789 with a GF Score™ of 97/100 and a GF Value™ of HK$7.70 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 814 Medical Devices & Instruments companies, AK Medical Holdings ranks better than 85.5% on this metric.
AK Medical Holdings (HKSE:01789) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
AK Medical Holdings EBITDA Margin % Related Terms
AK Medical Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for AK Medical Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01789 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, AK Medical Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AK Medical Holdings EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where AK Medical Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AK Medical Holdings (HKSE:01789) has a EBITDA Margin % of 26.68% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on AK Medical Holdings and its competitors. This is 20% below median its historical median of 33.28. Over the past decade, AK Medical Holdings' EBITDA Margin % has ranged from 24.21 to 42.34. According to the industry distribution chart, AK Medical Holdings ranks #118 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 14.5%.
Is AK Medical Holdings' EBITDA Margin % too high?
AK Medical Holdings' current EBITDA Margin % of 26.68% is 20% below median its 10-year median of 33.28. Over the past 10 years, this metric has ranged from a low of 24.21 to a high of 42.34. The Medical Devices & Instruments industry median EBITDA Margin % is 7.98. AK Medical Holdings' value of 26.68% is 234.3% above this industry median. Based on the distribution chart, AK Medical Holdings ranks #118 out of 814 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AK Medical Holdings has a GF Score™ of 97/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AK Medical Holdings' EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, AK Medical Holdings ranks #118 out of 814 companies for EBITDA Margin %. This places AK Medical Holdings in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.98. AK Medical Holdings' value of 26.68% is 234.3% above this benchmark. Historically, AK Medical Holdings' own EBITDA Margin % has ranged from 24.21 to 42.34 over the past decade. While the company's 10-year median is 33.28 vs. the industry median of 7.98, AK Medical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.98, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AK Medical Holdings's current EBITDA Margin % of 26.68% is 234.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on AK Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AK Medical Holdings's current EBITDA Margin % is 26.68%, which is 20% below median its own 10-year median of 33.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AK Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, AK Medical Holdings (HKSE:01789) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$7.70, compared to a current price of HK$5.02 — trading 34.9% below its estimated fair value. The current EBITDA Margin % is 26.68%, which is 20% below median its 10-year median of 33.28 and 234.3% above the Medical Devices & Instruments industry median of 7.98. AK Medical Holdings' overall GF Score™ is 97/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For AK Medical Holdings (HKSE:01789), the current EBITDA Margin % is 26.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AK Medical Holdings (HKSE:01789) Overvalued in 2026?
Based on GuruFocus' analysis, AK Medical Holdings stock appears to be undervalued.
The current stock price of HK$5.02 is trading 34.9% below its estimated GF Value™ of HK$7.70.
GuruFocus considers AK Medical Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:01789:
EBITDA Margin %: 26.68% (20% below median its 10-year median of 33.28)
GF Value™: HK$7.70 vs. price of HK$5.02 (34.9% below fair value)
Industry Position: 234.3% above the Medical Devices & Instruments median (#118 of 814)
No single metric tells the full story. See the HKSE:01789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AK Medical Holdings Ltd is an investment holding company, along with a subsidiary, engaged in designing, developing, producing and marketing orthopedic implants and related products. The principal activities of the group are manufacturing and sale of orthopedic joint implants, spinal implants, trauma implants, and their complete set of surgical instruments. Its geographical segments are China and the United Kingdom. It derives the majority of its revenue from China. The company offers Products and technologies: hip joint products, Knee joint products, Spine and Trauma Products, Oncology products, Digital products, and ICOS Medical Engineering Interaction Technology.
97GF Score
Get the complete analysis for HKSE:01789
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01789 has been successfully added to your 
